TY - JOUR
T1 - Effects of case volume and comprehensive stroke center capabilities on patient outcomes of clipping and coiling for subarachnoid hemorrhage
AU - on behalf of the J-ASPECT Study Collaborators
AU - Kurogi, Ryota
AU - Kada, Akiko
AU - Ogasawara, Kuniaki
AU - Kitazono, Takanari
AU - Sakai, Nobuyuki
AU - Hashimoto, Yoichiro
AU - Shiokawa, Yoshiaki
AU - Miyachi, Shigeru
AU - Matsumaru, Yuji
AU - Iwama, Toru
AU - Tominaga, Teiji
AU - Onozuka, Daisuke
AU - Nishimura, Ataru
AU - Arimura, Koichi
AU - Kurogi, Ai
AU - Ren, Nice
AU - Hagihara, Akihito
AU - Nakaoku, Yuriko
AU - Arai, Hajime
AU - Miyamoto, Susumu
AU - Nishimura, Kunihiro
AU - Iihara, Koji
N1 - Funding Information:
Details of the J-ASPECT Study Collaborators are listed in Supplementary eAppendix 8. We thank the Japan Neurosurgical Society (Profs. Takamasa Kayama and Hajime Arai) and the Japan Stroke Society (Profs. Norihiro Suzuki and Susumu Miyamoto) for their collaboration. The J-ASPECT Study (principal investigator: Koji Iihara) was supported by Grants-in-Aid from the Japanese Ministry of Health, Labour and Welfare and KAKENHI grants (25293314, 18H02914) from the Japan Society for the Promotion of Science. This research is partially supported by the Practical Research Project for Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus managed by the Japan Agency for Medical Research and Development (17ek0210088h0001, 18ek0210088h0002).
Publisher Copyright:
©AANS 2021, except where prohibited by US copyright law
PY - 2021/3
Y1 - 2021/3
N2 - OBJECTIVE Improved outcomes in patients with subarachnoid hemorrhage (SAH) treated at high-volume centers have been reported. The authors sought to examine whether hospital case volume and comprehensive stroke center (CSC) capabilities affect outcomes in patients treated with clipping or coiling for SAH. METHODS The authors conducted a nationwide retrospective cohort study in 27,490 SAH patients who underwent clipping or coiling in 621 institutions between 2010 and 2015 and whose data were collected from the Japanese nationwide J-ASPECT Diagnosis Procedure Combination database. The CSC capabilities of each hospital were assessed by use of a validated scoring system based on answers to a previously reported 25-item questionnaire (CSC score 1–25 points). Hospitals were classified into quartiles based on CSC scores and case volumes of clipping or coiling for SAH. RESULTS Overall, the absolute risk reductions associated with high versus low case volumes and high versus low CSC scores were relatively small. Nevertheless, in patients who underwent clipping, a high case volume (> 14 cases/yr) was significantly associated with reduced in-hospital mortality (Q1 as control, Q4 OR 0.71, 95% CI 0.55–0.90) but not with short-term poor outcome. In patients who underwent coiling, a high case volume (> 9 cases/yr) was associated with reduced in-hospital mortality (Q4 OR 0.69, 95% CI 0.53–0.90) and short-term poor outcomes (Q3 [> 5 cases/yr] OR 0.75, 95% CI 0.59–0.96 vs Q4 OR 0.65, 95% CI 0.51–0.82). A high CSC score (> 19 points) was significantly associated with reduced in-hospital mortality for clipping (OR 0.68, 95% CI 0.54–0.86) but not coiling treatment. There was no association between CSC capabilities and short-term poor outcomes.
AB - OBJECTIVE Improved outcomes in patients with subarachnoid hemorrhage (SAH) treated at high-volume centers have been reported. The authors sought to examine whether hospital case volume and comprehensive stroke center (CSC) capabilities affect outcomes in patients treated with clipping or coiling for SAH. METHODS The authors conducted a nationwide retrospective cohort study in 27,490 SAH patients who underwent clipping or coiling in 621 institutions between 2010 and 2015 and whose data were collected from the Japanese nationwide J-ASPECT Diagnosis Procedure Combination database. The CSC capabilities of each hospital were assessed by use of a validated scoring system based on answers to a previously reported 25-item questionnaire (CSC score 1–25 points). Hospitals were classified into quartiles based on CSC scores and case volumes of clipping or coiling for SAH. RESULTS Overall, the absolute risk reductions associated with high versus low case volumes and high versus low CSC scores were relatively small. Nevertheless, in patients who underwent clipping, a high case volume (> 14 cases/yr) was significantly associated with reduced in-hospital mortality (Q1 as control, Q4 OR 0.71, 95% CI 0.55–0.90) but not with short-term poor outcome. In patients who underwent coiling, a high case volume (> 9 cases/yr) was associated with reduced in-hospital mortality (Q4 OR 0.69, 95% CI 0.53–0.90) and short-term poor outcomes (Q3 [> 5 cases/yr] OR 0.75, 95% CI 0.59–0.96 vs Q4 OR 0.65, 95% CI 0.51–0.82). A high CSC score (> 19 points) was significantly associated with reduced in-hospital mortality for clipping (OR 0.68, 95% CI 0.54–0.86) but not coiling treatment. There was no association between CSC capabilities and short-term poor outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85102021684&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102021684&partnerID=8YFLogxK
U2 - 10.3171/2019.12.JNS192584
DO - 10.3171/2019.12.JNS192584
M3 - Article
C2 - 32168489
AN - SCOPUS:85102021684
SN - 0022-3085
VL - 134
SP - 929
EP - 939
JO - Journal of Neurosurgery
JF - Journal of Neurosurgery
IS - 3
ER -